
Christopher Brian Mckinley
Examiner (ID: 13265)
| Most Active Art Unit | 3781 |
| Art Unit(s) | 3781 |
| Total Applications | 591 |
| Issued Applications | 270 |
| Pending Applications | 9 |
| Abandoned Applications | 315 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 11662648
[patent_doc_number] => 20170151355
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-06-01
[patent_title] => 'TARGETED RADIOLABELED COMPOUNDS AND THEIR USE FOR THE TREATMENT AND DIAGNOSIS OF CANCER'
[patent_app_type] => utility
[patent_app_number] => 15/431402
[patent_app_country] => US
[patent_app_date] => 2017-02-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 23
[patent_figures_cnt] => 23
[patent_no_of_words] => 30441
[patent_no_of_claims] => 29
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15431402
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/431402 | TARGETED RADIOLABELED COMPOUNDS AND THEIR USE FOR THE TREATMENT AND DIAGNOSIS OF CANCER | Feb 12, 2017 | Abandoned |
Array
(
[id] => 11850359
[patent_doc_number] => 20170224852
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-08-10
[patent_title] => 'BENZAZEPIN-1-OL-DERIVED PET LIGANDS WITH HIGH IN VIVO NMDA SPECIFICITY'
[patent_app_type] => utility
[patent_app_number] => 15/427952
[patent_app_country] => US
[patent_app_date] => 2017-02-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 7014
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15427952
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/427952 | BENZAZEPIN-1-OL-DERIVED PET LIGANDS WITH HIGH IN VIVO NMDA SPECIFICITY | Feb 7, 2017 | Abandoned |
Array
(
[id] => 13899159
[patent_doc_number] => 20190038784
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-02-07
[patent_title] => TAU PET IMAGING LIGANDS
[patent_app_type] => utility
[patent_app_number] => 16/073992
[patent_app_country] => US
[patent_app_date] => 2017-02-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9601
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -10
[patent_words_short_claim] => 15
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16073992
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/073992 | TAU PET IMAGING LIGANDS | Jan 31, 2017 | Abandoned |
Array
(
[id] => 11850328
[patent_doc_number] => 20170224821
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-08-10
[patent_title] => 'IONIZING-RADIATION-RESPONSIVE COMPOSITIONS, METHODS, AND SYSTEMS'
[patent_app_type] => utility
[patent_app_number] => 15/412798
[patent_app_country] => US
[patent_app_date] => 2017-01-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 16
[patent_figures_cnt] => 16
[patent_no_of_words] => 17216
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15412798
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/412798 | IONIZING-RADIATION-RESPONSIVE COMPOSITIONS, METHODS, AND SYSTEMS | Jan 22, 2017 | Abandoned |
Array
(
[id] => 13824095
[patent_doc_number] => 20190015532
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-01-17
[patent_title] => QUANTITATIVE PET IMAGING OF TISSUE FACTOR EXPRESSION USING 18F-LABLED ACTIVE SITE INHIBITED FACTOR VII
[patent_app_type] => utility
[patent_app_number] => 16/070073
[patent_app_country] => US
[patent_app_date] => 2017-01-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4023
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -10
[patent_words_short_claim] => 83
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16070073
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/070073 | QUANTITATIVE PET IMAGING OF TISSUE FACTOR EXPRESSION USING 18F-LABLED ACTIVE SITE INHIBITED FACTOR VII | Jan 12, 2017 | Abandoned |
Array
(
[id] => 13840359
[patent_doc_number] => 20190023664
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-01-24
[patent_title] => RADIOLABELED ERLOTINIB ANALOGS AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 16/069546
[patent_app_country] => US
[patent_app_date] => 2017-01-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 23835
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -28
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16069546
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/069546 | Radiolabeled erlotinib analogs and uses thereof | Jan 11, 2017 | Issued |
Array
(
[id] => 15345209
[patent_doc_number] => 20200010496
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-01-09
[patent_title] => METHOD FOR PREPARING TRICARBONYL TECHNETIUM-99M INTERMEDIATE
[patent_app_type] => utility
[patent_app_number] => 16/464919
[patent_app_country] => US
[patent_app_date] => 2016-12-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4851
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -12
[patent_words_short_claim] => 30
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16464919
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/464919 | Method for preparing tricarbonyl technetium-99m intermediate | Dec 27, 2016 | Issued |
Array
(
[id] => 16341739
[patent_doc_number] => 20200306389
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-10-01
[patent_title] => RADIOLABELLED mGluR2/3 PET LIGANDS
[patent_app_type] => utility
[patent_app_number] => 16/061437
[patent_app_country] => US
[patent_app_date] => 2016-12-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8307
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -11
[patent_words_short_claim] => 15
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16061437
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/061437 | Radiolabelled mGluR2/3 pet ligands | Dec 15, 2016 | Issued |
Array
(
[id] => 13729923
[patent_doc_number] => 20180369429
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-12-27
[patent_title] => RADIOLABELLED mGluR2/3 PET LIGANDS
[patent_app_type] => utility
[patent_app_number] => 16/061674
[patent_app_country] => US
[patent_app_date] => 2016-12-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7471
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -10
[patent_words_short_claim] => 15
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16061674
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/061674 | Radiolabelled mGluR2/3 PET ligands | Dec 15, 2016 | Issued |
Array
(
[id] => 11542565
[patent_doc_number] => 20170096390
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-04-06
[patent_title] => 'FLUORINATED 2-AMINO-4-(BENZYLAMINO)PHENYLCARBAMATE DERIVATIVES'
[patent_app_type] => utility
[patent_app_number] => 15/380216
[patent_app_country] => US
[patent_app_date] => 2016-12-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15632
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15380216
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/380216 | FLUORINATED 2-AMINO-4-(BENZYLAMINO)PHENYLCARBAMATE DERIVATIVES | Dec 14, 2016 | Abandoned |
Array
(
[id] => 16053371
[patent_doc_number] => 20200188540
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-06-18
[patent_title] => CONFORMATIONALLY STRAINED TRANS-CYCLOALKENES FOR RADIOLABELING
[patent_app_type] => utility
[patent_app_number] => 16/062756
[patent_app_country] => US
[patent_app_date] => 2016-12-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8592
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -8
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16062756
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/062756 | CONFORMATIONALLY STRAINED TRANS-CYCLOALKENES FOR RADIOLABELING | Dec 13, 2016 | Abandoned |
Array
(
[id] => 11729215
[patent_doc_number] => 20170190658
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-07-06
[patent_title] => 'IMAGING AGENTS'
[patent_app_type] => utility
[patent_app_number] => 15/367856
[patent_app_country] => US
[patent_app_date] => 2016-12-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 15
[patent_figures_cnt] => 15
[patent_no_of_words] => 15506
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15367856
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/367856 | IMAGING AGENTS | Dec 1, 2016 | Abandoned |
Array
(
[id] => 16251323
[patent_doc_number] => 20200260697
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-08-20
[patent_title] => METHODS OF MOUSE CLINICAL TRIAL
[patent_app_type] => utility
[patent_app_number] => 16/464275
[patent_app_country] => US
[patent_app_date] => 2016-11-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14038
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -22
[patent_words_short_claim] => 126
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16464275
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/464275 | METHODS OF MOUSE CLINICAL TRIAL | Nov 28, 2016 | Abandoned |
Array
(
[id] => 11618412
[patent_doc_number] => 20170128599
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-05-11
[patent_title] => 'FOLATE-CONJUGATES AND CORRESPONDING METAL-CHELATE COMPLEXES FOR USE IN DIAGNOSTIC IMAGING AND RADIOTHERAPY'
[patent_app_type] => utility
[patent_app_number] => 15/358787
[patent_app_country] => US
[patent_app_date] => 2016-11-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 18933
[patent_no_of_claims] => 47
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15358787
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/358787 | FOLATE-CONJUGATES AND CORRESPONDING METAL-CHELATE COMPLEXES FOR USE IN DIAGNOSTIC IMAGING AND RADIOTHERAPY | Nov 21, 2016 | Abandoned |
Array
(
[id] => 13586665
[patent_doc_number] => 20180344881
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-12-06
[patent_title] => FORMULATIONS FOR 2-HETEROARYL SUBSTITUTED BENZOFURANS
[patent_app_type] => utility
[patent_app_number] => 15/777640
[patent_app_country] => US
[patent_app_date] => 2016-11-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9154
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -60
[patent_words_short_claim] => 19
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15777640
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/777640 | FORMULATIONS FOR 2-HETEROARYL SUBSTITUTED BENZOFURANS | Nov 20, 2016 | Abandoned |
Array
(
[id] => 11690816
[patent_doc_number] => 20170166531
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-06-15
[patent_title] => '2-ALKOXY-11-HYDROXYAPORPHINE DERIVATIVES AND USES THEREOF'
[patent_app_type] => utility
[patent_app_number] => 15/347394
[patent_app_country] => US
[patent_app_date] => 2016-11-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 18299
[patent_no_of_claims] => 30
[patent_no_of_ind_claims] => 10
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15347394
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/347394 | 2-alkoxy-11-hydroxyaporphine derivatives and uses thereof | Nov 8, 2016 | Issued |
Array
(
[id] => 14360043
[patent_doc_number] => 10301308
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-05-28
[patent_title] => Azetidine derivatives for tau imaging
[patent_app_type] => utility
[patent_app_number] => 15/763608
[patent_app_country] => US
[patent_app_date] => 2016-11-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 9110
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 12
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15763608
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/763608 | Azetidine derivatives for tau imaging | Nov 3, 2016 | Issued |
Array
(
[id] => 16518740
[patent_doc_number] => 10869942
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-12-22
[patent_title] => Method
[patent_app_type] => utility
[patent_app_number] => 15/771152
[patent_app_country] => US
[patent_app_date] => 2016-10-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 3
[patent_no_of_words] => 14227
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 142
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15771152
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/771152 | Method | Oct 25, 2016 | Issued |
Array
(
[id] => 16190765
[patent_doc_number] => 20200231614
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-07-23
[patent_title] => PSMA TARGETED RADIOHALOGENATED UREAS FOR CANCER RADIOTHERAPY
[patent_app_type] => utility
[patent_app_number] => 15/769865
[patent_app_country] => US
[patent_app_date] => 2016-10-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17988
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 223
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15769865
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/769865 | PSMA TARGETED RADIOHALOGENATED UREAS FOR CANCER RADIOTHERAPY | Oct 20, 2016 | Abandoned |
Array
(
[id] => 14040901
[patent_doc_number] => 20190076557
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-03-14
[patent_title] => HYALURONAN SN-117M COLLOID FOR RADIOSYNOVIORTHESIS AND SYMPTOMATIC THERAPY RELATED APPLICATIONS
[patent_app_type] => utility
[patent_app_number] => 15/765559
[patent_app_country] => US
[patent_app_date] => 2016-10-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 1746
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -9
[patent_words_short_claim] => 12
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15765559
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/765559 | HYALURONAN SN-117M COLLOID FOR RADIOSYNOVIORTHESIS AND SYMPTOMATIC THERAPY RELATED APPLICATIONS | Oct 4, 2016 | Abandoned |